Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Shares Outstanding (2016 - 2025)

Organogenesis Holdings (ORGO) has 4 years of Shares Outstanding data on record, last reported at $1.7 million in Q2 2020.

  • For Q2 2020, Shares Outstanding rose 157.27% year-over-year to $1.7 million; the TTM value through Jun 2020 reached $1.7 million, up 157.27%, while the annual FY2019 figure was $675990.0, 0.0% changed from the prior year.
  • Shares Outstanding reached $1.7 million in Q2 2020 per ORGO's latest filing, down from $1.9 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $1.9 million in Q4 2019 and bottomed at $675990.0 in Q4 2017.
  • Average Shares Outstanding over 4 years is $1.2 million, with a median of $675990.0 recorded in 2017.
  • Peak YoY movement for Shares Outstanding: changed 0.0% in 2018, then surged 157.27% in 2020.
  • A 4-year view of Shares Outstanding shows it stood at $675990.0 in 2017, then changed by 0.0% to $675990.0 in 2018, then changed by 0.0% to $675990.0 in 2019, then skyrocketed by 157.27% to $1.7 million in 2020.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $1.7 million in Q2 2020, $675990.0 in Q1 2020, and $675990.0 in Q4 2019.